Osteoboost Health, the developer of the first and only FDA-cleared prescription medical device for low bone density, today released its inaugural State of Bones Report, designed to shine a light on the perspectives and experiences of women and their bone health as they enter the perimenopause-menopause transition and beyond…
Read More
June 17, 2026
Nevoral


